Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Utilizing chemokines in cancer immunotherapy
Florian Märkl, Duc Huynh, Stefan Endres, et al.
Trends in cancer (2022) Vol. 8, Iss. 8, pp. 670-682
Closed Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

How chemokines organize the tumour microenvironment
Thorsten R. Mempel, Julia K. Lill, Lukas M. Altenburger
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 28-50
Closed Access | Times Cited: 92
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 63
Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1143-1143
Open Access | Times Cited: 50
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 35
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 28
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 2
The role of CXCR3 and its ligands in cancer
Xiaoming Wang, Yangyang Zhang, Sen Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 53
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
Hanli Xu, Shuye Lin, Ziyun Zhou, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 739-776
Open Access | Times Cited: 29
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
Rongyang Li, Bing Huang, Hui Tian, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 22
Engineered bacteria in tumor immunotherapy
Hua Chen, Yinrui Zhu, Chonghai Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216817-216817
Closed Access | Times Cited: 11
Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single‐cell RNA sequencing
Yunfang Yu, Haizhu Chen, Wenhao Ouyang, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 8
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Parps in immune response: Potential targets for cancer immunotherapy
S Wang, Jingling Huang, T. X. Zeng, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116803-116803
Closed Access | Times Cited: 1
Chimeric antigen receptor therapy meets mRNA technology
Jiacai Wu, Weigang Wu, Boping Zhou, et al.
Trends in biotechnology (2023) Vol. 42, Iss. 2, pp. 228-240
Open Access | Times Cited: 21
Surgically Derived Cancer Cell Membrane-Coated R837-Loaded Poly(2-Oxazoline) Nanoparticles for Prostate Cancer Immunotherapy
Shengxian Li, Dong Si, Jing Wu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 6, pp. 7878-7886
Closed Access | Times Cited: 19
Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8 + T cells towards the center of human lung tumors
Demi Brownlie, Andreas von Kries, Giampiero Valenzano, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody
Shenxin Zeng, Mingfei Wu, Yuyuan Jin, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116206-116206
Closed Access | Times Cited: 6
Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM)
Jun Du, Lin Zheng, Xue-Hang Fu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity
Minjie Pan, Xiao‐Shan Wei, Xuan Xiang, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 8, pp. 2306-2320
Closed Access | Times Cited: 15
Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect
Bo Chen, Ruijie Huang, Wei Zeng, et al.
Biomaterials (2023) Vol. 305, pp. 122434-122434
Closed Access | Times Cited: 14
Trends in the incidence and survival of cancer in individuals aged 55 years and older in the United States, 1975–2019
Junpeng Cui, Ding Rong-mei, Haifeng Liu, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations
Maryam Mashhadi Abolghasem Shirazi, Tayebeh Azam Saedi, Zahra Samadi Moghaddam, et al.
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108611-108611
Closed Access | Times Cited: 5
LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt/ERK/NF-κB signaling
Sujian Xiao, Tong Yu, Fulan Yang, et al.
Biochemistry and Cell Biology (2025)
Closed Access
Integration of Metabolomics and Transcriptomics to Reveal the Antitumor Mechanism of Dendrobium officinale Polysaccharide-Based Nanocarriers in Enhancing Photodynamic Immunotherapy in Colorectal Cancer
Shengchang Tao, Huan Wang, Qiufeng Ji, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 97-97
Open Access
Page 1 - Next Page

Scroll to top